Jubilant Pharmova has entered into Share Purchase agreement, and Share Subscription and Shareholders agreement on April 1, 2022 for acquiring equity and preference shares of SPV Laboratories (Greencure). Greencure products have differentiated positioning, combining the best of Ayurveda and German herbal science.
The company has obtained multiple international certifications to strengthen their credibility. The market is being driven by a growing shift towards natural products, as well as rise in chronic diseases and growing health awareness. There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution. Aggregate cost of acquisition is Rs 8.75 crore for acquiring 25.21% stake.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.50 |
| Dr. Reddys Lab | 1237.75 |
| Cipla | 1238.15 |
| Zydus Lifesciences | 941.45 |
| Lupin | 2330.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: